First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion
IntroductionBone and joint infections (BJIs) caused by multidrug-resistant bacteria are becoming more frequent. However, data on the use of novel β-lactam/β-lactamase inhibitors, such as imipenem/cilastatin/relebactam (I-R) and meropenem/vaborbactam (MVB), to treat BJIs is lacking. Furthermore, prol...
Saved in:
Main Authors: | Paul Laffont-Lozes (Author), Tayma Naciri (Author), Alix Pantel (Author), Aurélie Martin (Author), Anne-Sophie (Author), Vincent Haignere (Author), Paul Loubet (Author), Albert Sotto (Author), Romaric Larcher (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of Beta-Lactam Allergic and Non-Beta-Lactam Allergic Patients with Intra-Abdominal Infection: A Case-Control Study
by: Tayma Naciri, et al.
Published: (2022) -
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France
by: Paul Laffont-Lozes, et al.
Published: (2023) -
Covid-19 pandemic: an opportunity to seize to increase awareness and vaccine coverage in at-risk populations
by: Paul Loubet, et al.
Published: (2021) -
Cost-effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia
by: Jaesh Naik, et al.
Published: (2023) -
In Vivo-Acquired Resistance to Daptomycin during Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
by: Adeline Boutet-Dubois, et al.
Published: (2023)